Central Asia vs Mauritius: Proportion of the target population who received the final dose of
Central Asia
59.0%
in 2024
Mauritius
92.0%
in 2024
Central Asia rank
8th
Mauritius rank
6th
Proportion of the target population who received the final dose of over time
- Central Asia
- Mauritius
How they compare
Mauritius currently reports 92.0% against 59.0% in Central Asia, a difference of 33.0%.
That makes Mauritius's figure about 1.6 times Central Asia's.
The two have swapped places 2 times across 8 shared years of data; in 2017 it was Mauritius ahead.
Central Asia ranks 8th and Mauritius ranks 6th of 35 groups.
Mauritius has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central Asia | Mauritius | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.0% | 77.3% | 69.3% | Mauritius |
| 2020s | 52.0% | 54.2% | 2.2% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Central Asia or Mauritius?
- Mauritius, at 92.0% against 59.0% in Central Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Central Asia and Mauritius?
- 33.0%, with Mauritius ahead.
- How many years of comparable data are there for Central Asia and Mauritius?
- 8 years are reported by both, from 2017 to 2024.
- How do Central Asia and Mauritius rank globally for proportion of the target population who received the final dose of?
- Central Asia ranks 8th and Mauritius ranks 6th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.